594 related articles for article (PubMed ID: 26679414)
1. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.
Zevin AS; McKinnon L; Burgener A; Klatt NR
Curr Opin HIV AIDS; 2016 Mar; 11(2):182-90. PubMed ID: 26679414
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiome and HIV-1 pathogenesis: a two-way street.
Dillon SM; Frank DN; Wilson CC
AIDS; 2016 Nov; 30(18):2737-2751. PubMed ID: 27755100
[TBL] [Abstract][Full Text] [Related]
3. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
Bandera A; De Benedetto I; Bozzi G; Gori A
Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
[TBL] [Abstract][Full Text] [Related]
4. Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.
Tincati C; Douek DC; Marchetti G
AIDS Res Ther; 2016; 13():19. PubMed ID: 27073405
[TBL] [Abstract][Full Text] [Related]
5. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
Dillon SM; Kibbie J; Lee EJ; Guo K; Santiago ML; Austin GL; Gianella S; Landay AL; Donovan AM; Frank DN; McCARTER MD; Wilson CC
AIDS; 2017 Feb; 31(4):511-521. PubMed ID: 28002063
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the Microbiota to Intestinal Homeostasis and its Role in the Pathogenesis of HIV-1 Infection.
Luján JA; Rugeles MT; Taborda NA
Curr HIV Res; 2019; 17(1):13-25. PubMed ID: 30854974
[TBL] [Abstract][Full Text] [Related]
7. Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.
Mudd JC; Brenchley JM
J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S58-66. PubMed ID: 27625432
[TBL] [Abstract][Full Text] [Related]
8. A Summary of the First HIV Microbiome Workshop 2015.
Williams B; Mirmonsef P; Boucher CA; Bushman F; Carrington-Lawrence S; Collman RG; Dandekar S; Dang Q; Malaspina A; Paredes R; Stone A; Landay A
AIDS Res Hum Retroviruses; 2016; 32(10-11):935-941. PubMed ID: 27267576
[TBL] [Abstract][Full Text] [Related]
9. Altered Immunoglobulin Repertoire and Decreased IgA Somatic Hypermutation in the Gut during Chronic HIV-1 Infection.
Jones ST; Guo K; Cooper EH; Dillon SM; Wood C; Nguyen DH; Shen G; Barrett BS; Frank DN; Kroehl M; Janoff EN; Kechris K; Wilson CC; Santiago ML
J Virol; 2022 Sep; 96(17):e0097622. PubMed ID: 35938870
[TBL] [Abstract][Full Text] [Related]
10. A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop.
Williams B; Ghosh M; Boucher C; Bushman F; Carrington-Lawrence S; Collman RG; Dandekar S; Dang Q; Malaspina A; Paredes R; Wilson C; Cardoso SP; Lagenaur L; Santos J; Joy C; Landay A
AIDS Res Hum Retroviruses; 2020 May; 36(5):349-356. PubMed ID: 31914785
[TBL] [Abstract][Full Text] [Related]
11. The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection.
Zhang Y; Xie Z; Zhou J; Li Y; Ning C; Su Q; Ye L; Ai S; Lai J; Pan P; Liu N; Liao Y; Su Q; Li Z; Liang H; Cui P; Huang J
Front Immunol; 2022; 13():1020822. PubMed ID: 36685491
[TBL] [Abstract][Full Text] [Related]
12. Microbiota and Probiotics in Health and HIV Infection.
D'Angelo C; Reale M; Costantini E
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28621726
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review.
Ouyang J; Zaongo SD; Zhang X; Qi M; Hu A; Wu H; Chen Y
Front Immunol; 2021; 12():755890. PubMed ID: 35069530
[TBL] [Abstract][Full Text] [Related]
14. Role of the lung microbiome in HIV pathogenesis.
Shenoy MK; Lynch SV
Curr Opin HIV AIDS; 2018 Jan; 13(1):45-52. PubMed ID: 29035946
[TBL] [Abstract][Full Text] [Related]
15. Microbial translocation, immune activation, and HIV disease.
Klatt NR; Funderburg NT; Brenchley JM
Trends Microbiol; 2013 Jan; 21(1):6-13. PubMed ID: 23062765
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
17. The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
Missailidis C; Neogi U; Stenvinkel P; Trøseid M; Nowak P; Bergman P
AIDS; 2018 Jul; 32(12):1589-1598. PubMed ID: 29620717
[TBL] [Abstract][Full Text] [Related]
18. The functional consequences of the microbiome in HIV: insights from metabolomic studies.
Serrano-Villar S; Moreno S; Ferrer M
Curr Opin HIV AIDS; 2018 Jan; 13(1):88-94. PubMed ID: 29035945
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.
Vujkovic-Cvijin I; Dunham RM; Iwai S; Maher MC; Albright RG; Broadhurst MJ; Hernandez RD; Lederman MM; Huang Y; Somsouk M; Deeks SG; Hunt PW; Lynch SV; McCune JM
Sci Transl Med; 2013 Jul; 5(193):193ra91. PubMed ID: 23843452
[TBL] [Abstract][Full Text] [Related]
20. Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease.
El-Far M; Tremblay CL
Curr Opin HIV AIDS; 2018 Jan; 13(1):38-44. PubMed ID: 29045253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
